Please provide your email address to receive an email when new articles are posted on . Vaginal estrogen, dehydroepiandrosterone, moisturizers and oral ospemifene may improve genitourinary symptoms of ...

Please provide your email address to receive an email when new articles are posted on . At 12 weeks, vaginal hyaluronic acid and vaginal estrogen were associated with genitourinary syndrome of ...

CHICAGO--(BUSINESS WIRE)--Dr. Lauren Streicher, a leading gynecologist and menopause expert, addresses the widespread issue of genitourinary syndrome of menopause (GSM) in her latest podcast episode.

In women with an intact uterus: moderate-to-severe vasomotor symptoms of menopause; moderate-to-severe vulvar and vaginal atrophy associated with menopause. Angeliq combines the estrogen, estradiol, ...

Vaginal estrogens, vaginal dehydroepiandrosterone (DHEA), and oral ospemifene can improve vulvovaginal dryness and dyspareunia associated with genitourinary syndrome of menopause (GSM), according to a ...

Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...

Genitourinary syndrome of menopause, urinary incontinence or vagina laxity can imply serious problems in terms of Women's quality of life and sexual health. Nowadays, beyond creams, moisturizers and ...

LJUBLJANA, Slovenia, Aug. 27, 2019 /CNW/ -- In an industry first achievement, Fotona's Dynamis Laser System received clearance by Health Canada, Canada's Food and Drugs Act and Regulations Agency, to ...

As women age, they are more susceptible to vaginal dryness and pain during intercourse because of vulvovaginal atrophy (VVA). A new study suggests that ospemifene and systemic hormone therapy both ...